Does RELUGOLIX Cause Prostatic specific antigen increased? 335 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 335 reports of Prostatic specific antigen increased have been filed in association with RELUGOLIX (Orgovyx). This represents 1.6% of all adverse event reports for RELUGOLIX.
335
Reports of Prostatic specific antigen increased with RELUGOLIX
1.6%
of all RELUGOLIX reports
13
Deaths
49
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From RELUGOLIX?
Of the 335 reports, 13 (3.9%) resulted in death, 49 (14.6%) required hospitalization.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 335 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
OLAPARIB (176)
Which RELUGOLIX Alternatives Have Lower Prostatic specific antigen increased Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM